Premium
The burden of adverse drug events
Author(s) -
Breckenridge Alasdair
Publication year - 2015
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.12507
Subject(s) - drug , adverse effect , intensive care medicine , medicine , drug reaction , adverse drug reaction , health care , patient safety , pharmacology , risk analysis (engineering) , medical emergency , economics , economic growth
Drug safety should be considered as part of the balance between benefit and risk, and represents a burden to the patient, the healthcare professional, the regulator and industry. Each of these has a different view on adverse drug reactions and these are discussed in this article.